Novozymes A/S
CSE:NSIS B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NSIS B
Watchlist
Price: 400.7 DKK -0.82% Market Closed
Market Cap: 166.1B DKK

Wall Street
Price Targets

NSIS B Price Targets Summary
Novozymes A/S

There are no price targets for NSIS B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Novozymes A/S Competitors:
Price Targets
ELM
Elementis PLC
23% Upside
688065
Cathay Biotech Inc
36% Upside
300398
PhiChem Corp
14% Upside
002466
Tianqi Lithium Corp
6% Upside
ANCOMNY
Nylex (Malaysia) Bhd
31% Upside
PRIVISCL
Privi Speciality Chemicals Ltd
29% Upside
ADVENZYMES
Advanced Enzyme Technologies Ltd
46% Upside
6988
Nitto Denko Corp
3% Upside

Revenue
Forecast

Revenue Estimate
Novozymes A/S

For the last 7 years the compound annual growth rate for Novozymes A/S's revenue is 3%. The projected CAGR for the next 2 years is -55%.

3%
Past Growth
-55%
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Novozymes A/S

Operating Income forecast
is not available for
Novozymes A/S

Net Income
Forecast

Net Income Estimate
Novozymes A/S

For the last 7 years the compound annual growth rate for Novozymes A/S's net income is 0%. The projected CAGR for the next 2 years is -56%.

0%
Past Growth
-56%
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NSIS B's stock price target?
Not Available

NSIS B doesn't have any price targets made by Wall Street professionals.

What is Novozymes A/S's Revenue forecast?
Projected CAGR
-55%

For the last 7 years the compound annual growth rate for Novozymes A/S's revenue is 3%. The projected CAGR for the next 2 years is -55%.

What is Novozymes A/S's Net Income forecast?
Projected CAGR
-56%

For the last 7 years the compound annual growth rate for Novozymes A/S's net income is 0%. The projected CAGR for the next 2 years is -56%.

Back to Top